David A. Siegel Bio Xcel Therapeutics, Inc. Transaction History

Two Sigma Advisers, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.49 - $11.85 $184,011 - $875,715	73,900 New	73,900 $186,000
Q1 2023 May 15, 2023	BUY	$17.7 - $33.24 $495,600 - $930,720	28,000 Added 95.24%	57,400 $1.07 Million
Q4 2022 Feb 14, 2023	SELL	$10.25 - $22.43 $361,825 - $791,779	-35,300 Reduced 54.56%	29,400 $631,000
Q3 2022 Nov 14, 2022	SELL	$11.19 - $17.89 $386,055 - $617,205	-34,500 Reduced 34.78%	64,700 $765,000
Q2 2022 Aug 15, 2022	BUY	$9.03 - $21.55 $764,841 - $1.83 Million	84,700 Added 584.14%	99,200 $1.31 Million
Q1 2022 May 16, 2022	BUY	$15.0 - $22.83 $24,000 - $36,528	1,600 Added 12.4%	14,500 $303,000
Q4 2021 Feb 14, 2022	SELL	$20.12 - $35.09 $490,928 - $856,196	-24,400 Reduced 65.42%	12,900 $262,000
Q3 2021 Nov 15, 2021	SELL	$23.84 - $32.03 $665,136 - $893,637	-27,900 Reduced 42.79%	37,300 $1.13 Million
Q2 2021 Aug 16, 2021	SELL	$29.06 - $38.83 $432,994 - $578,567	-14,900 Reduced 18.6%	65,200 $1.9 Million
Q1 2021 May 17, 2021	BUY	$39.04 - $64.6 $2.39 Million - $3.96 Million	61,300 Added 326.06%	80,100 $3.46 Million
Q4 2020 Feb 16, 2021	BUY	$42.46 - $56.58 $798,248 - $1.06 Million	18,800 New	18,800 $869,000
Q3 2020 Nov 16, 2020	SELL	$37.44 - $64.63 $1.02 Million - $1.76 Million	-27,200 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$17.62 - $58.71 $479,264 - $1.6 Million	27,200 New	27,200 $1.44 Million

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $14.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.